BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,759,001 | -17.2% | 232,088 | 0.0% | 0.35% | -17.3% |
Q2 2023 | $10,573,929 | +4.1% | 232,088 | -7.3% | 0.43% | +0.5% |
Q1 2023 | $10,156,062 | -20.4% | 250,396 | 0.0% | 0.42% | -20.3% |
Q4 2022 | $12,762,684 | -12.8% | 250,396 | -7.9% | 0.53% | -21.2% |
Q3 2022 | $14,638,000 | -16.1% | 271,796 | 0.0% | 0.68% | -9.7% |
Q2 2022 | $17,457,000 | -17.2% | 271,796 | 0.0% | 0.75% | -7.3% |
Q1 2022 | $21,076,000 | -9.9% | 271,796 | -0.2% | 0.81% | -7.2% |
Q4 2021 | $23,382,000 | +9.1% | 272,396 | +2.3% | 0.87% | -0.9% |
Q3 2021 | $21,422,000 | -0.1% | 266,352 | 0.0% | 0.88% | +3.8% |
Q2 2021 | $21,440,000 | -4.6% | 266,352 | 0.0% | 0.85% | -8.9% |
Q1 2021 | $22,465,000 | +6.7% | 266,352 | +1.5% | 0.93% | -2.3% |
Q4 2020 | $21,063,000 | +3.1% | 262,506 | +3.3% | 0.95% | -8.5% |
Q3 2020 | $20,431,000 | -6.6% | 254,061 | 0.0% | 1.04% | -10.8% |
Q2 2020 | $21,874,000 | +3.8% | 254,061 | -2.1% | 1.17% | -9.8% |
Q1 2020 | $21,066,000 | -3.6% | 259,461 | -0.7% | 1.29% | +23.3% |
Q4 2019 | $21,844,000 | -4.4% | 261,229 | 0.0% | 1.05% | -9.3% |
Q3 2019 | $22,849,000 | +6.6% | 261,229 | -0.2% | 1.16% | +5.4% |
Q2 2019 | $21,426,000 | +9.0% | 261,629 | 0.0% | 1.10% | +7.2% |
Q1 2019 | $19,654,000 | +14.1% | 261,629 | 0.0% | 1.02% | +5.0% |
Q4 2018 | $17,220,000 | -14.6% | 261,629 | 0.0% | 0.97% | -1.1% |
Q3 2018 | $20,168,000 | +2.4% | 261,629 | -1.9% | 0.98% | -2.5% |
Q2 2018 | $19,702,000 | +11.7% | 266,829 | -1.6% | 1.01% | +12.5% |
Q1 2018 | $17,637,000 | -0.8% | 271,173 | -1.5% | 0.90% | +5.4% |
Q4 2017 | $17,787,000 | -17.9% | 275,173 | -20.3% | 0.85% | -13.9% |
Q3 2017 | $21,659,000 | +2.3% | 345,173 | -1.3% | 0.99% | +10.6% |
Q2 2017 | $21,173,000 | +16.7% | 349,733 | -0.0% | 0.90% | +15.8% |
Q1 2017 | $18,139,000 | +17.0% | 349,773 | 0.0% | 0.77% | +12.5% |
Q4 2016 | $15,509,000 | -1.2% | 349,773 | +6.1% | 0.69% | -2.6% |
Q3 2016 | $15,697,000 | +4.6% | 329,773 | -0.6% | 0.70% | +4.6% |
Q2 2016 | $15,009,000 | +8.1% | 331,917 | -1.8% | 0.67% | +5.0% |
Q1 2016 | $13,889,000 | +7.5% | 338,067 | -0.2% | 0.64% | +4.9% |
Q4 2015 | $12,924,000 | +16.5% | 338,759 | +0.3% | 0.61% | +8.9% |
Q3 2015 | $11,097,000 | -53.1% | 337,834 | -0.1% | 0.56% | -48.0% |
Q2 2015 | $23,658,000 | +1.9% | 338,302 | -0.1% | 1.08% | +3.0% |
Q1 2015 | $23,208,000 | -6.5% | 338,802 | 0.0% | 1.05% | -5.9% |
Q4 2014 | $24,831,000 | +2.1% | 338,802 | 0.0% | 1.12% | -1.2% |
Q3 2014 | $24,316,000 | -0.8% | 338,802 | -0.1% | 1.13% | -0.5% |
Q2 2014 | $24,524,000 | -1.7% | 339,202 | 0.0% | 1.14% | -5.3% |
Q1 2014 | $24,960,000 | +4.8% | 339,202 | -1.0% | 1.20% | +3.9% |
Q4 2013 | $23,819,000 | +5.9% | 342,468 | 0.0% | 1.15% | -3.6% |
Q3 2013 | $22,497,000 | -5.3% | 342,468 | -0.2% | 1.20% | -8.3% |
Q2 2013 | $23,763,000 | – | 343,034 | – | 1.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |